BACTEREMIC MELIOIDOSIS IN SOUTHERN VIETNAM: CLINICAL CHARACTERISTICS AND TREATMENT
Main Article Content
Abstract
Background: Melioidosis is a serious infectious disease caused by Burkholderia pseudomallei, with its bacteremic form associated with high mortality. However, data on clinical characteristics and treatment outcomes of this form in Vietnam remain limited.
Objectives: To describe the epidemiological, clinical, laboratory, treatment-related characteristics and outcomes of patients with bacteremic melioidosis.
Methods: This was a retrospective case series conducted at a tertiary hospital in Vietnam. All patients discharged in 2023 with a diagnosis of bacteremia due to B. pseudomallei (confirmed by positive blood culture) were included. Data were extracted from medical records and analyzed using SPSS version 25.0.
Results: Among 33 patients, the median age was 51 years; 72.7% were male, and 87.9% had diabetes mellitus. The overall mortality rate was 9.1%. Only 9.1% had isolated bacteremia, while the majority had multiple coexisting localized infections, most commonly pulmonary abscesses, soft tissue abscesses,
osteoarticular involvement, and central nervous system infections. B. pseudomallei remained highly susceptible to imipenem, meropenem, ceftazidime, and TMP-SMX. Meropenem was the most frequently
used empirical antibiotic.
Conclusions: Bacteremic melioidosis in Vietnam frequently presents with multiple localized abscesses and occurs predominantly in patients with diabetes. Timely identification of multi-organ involvement and appropriate antibiotic selection are essential for effective treatment.
Article Details
Keywords
Melioidosis, bacteremia, Burkholderia pseudomallei, diabetes mellitus, multiple organ abscesses
References
2. Chakravorty A, Heath CH. Melioidosis: An updated review. Aust J Gen Pract. 2019;48(5).
3. Chayangsu S, Suankratay C, Tantraworasin A, others. Predictive factors associated with in-hospital mortality of melioidosis: A cohort study. Unpublished. 2024.
4. Meumann EM, Cheng AC, Ward L, Currie BJ. Clinical features and epidemiology of melioidosis
pneumonia: Results from a 21-year study. Clin Infect Dis. 2012;54(3):362-9.
5. Suputtamongkol Y, Chaowagul W, Chetchotisakd P. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis. 1999;29(2):408-13.
6. Baek S, Lee SJ. Clinical characteristics and laboratory biomarkers in ICU-admitted septic patients with and without bacteemia. 2023.
7. Ramakrishnan N, others. Melioidosis in critical care: A review. Indian J Crit Care Med. 2021;25(Suppl 2):S161-5. Patwardhan SA. Infectious Diseases in Critical Care. Springer; 2022.
9. Guide JHA. Burkholderia pseudomallei (Melioidosis) [Internet]. 2023. Available from: https://
www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540748/all/Burkholderia_
pseudomallei__Melioidosis_.